Macrogenics (MGNX) Total Liabilities (2012 - 2026)

Macrogenics (MGNX) has 15 years of Total Liabilities data on file, last reported at $196.7 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $196.7 million, up 35.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $196.7 million (up 35.22% YoY), and the FY2025 annual result was $201.3 million, up 38.23% from the prior year.
• Total Liabilities fell to $196.7 million in Q1 2026 per MGNX's latest filing, from $201.3 million in the prior quarter.
• Over five years, Total Liabilities peaked at $234.2 million in Q1 2023 and troughed at $72.4 million in Q3 2022.
• A 5-year average of $150.7 million and a median of $145.4 million in 2025 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities surged 151.24% in 2023, then sank 39.32% in 2024.
• A 5-year view of Total Liabilities shows it stood at $138.5 million in 2022, then increased by 5.31% to $145.8 million in 2023, then dropped by 0.14% to $145.6 million in 2024, then surged by 38.23% to $201.3 million in 2025, then declined by 2.28% to $196.7 million in 2026.
• Business Quant data shows MGNX's Total Liabilities at $196.7 million in Q1 2026, $201.3 million in Q4 2025, and $203.8 million in Q3 2025.